Summary
- Current Price
- As of today, CLLS price is $3.77, up +8.02% in the most recent trading session on
- Current Price All-Time High
- CLLS price is currently -92.46% below its historical high of $50.00 set on
- Market Cap
- CLLS current market cap is $385M, up +151.44% over the past 365 days
- PE Ratio
- CLLS PE ratio is unknown
- Revenue
- CLLS current annual revenue is $41.43M, up +5387.64% year-over-year
- Next Earnings
- The next earnings release for CLLS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cellectis S.A. |
| Ticker | NASDAQ: CLLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | cellectis.com |
| Employees | 216 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.77 | ||
| Price, 1D Change | +8.02% | |
| $385M | ||
| - | ||
| - | ||
| 0.77 | ||
| $41M | ||
| Revenue, 1Y Change | +5,387.64% | |
| -$0.41 | ||
| EPS, 1Y Change | +77.14% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.41 | ||
| EPS Estimate | -$0.47 | |
| EPS Est. Change | -15.99% | |
| $41.43M | ||
| Revenue Estimate | $62.14M | |
| Revenue Est. Change | +49.99% | |
| $3.77 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +85.68% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.27 | -$1.77 | -39.57% | |
| -$0.70 | -$0.41 | +42.11% | |
| -$0.47 | N/A | -15.99% | |
| -$0.62 | N/A | -53.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $21.47M | $755.00K | -96.48% | |
| $40.92M | $41.43M | +1.26% | |
| $62.14M | N/A | +49.99% | |
| $63.74M | N/A | +53.84% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +146.41% | ||
| +60.43% | ||
| +151.44% | ||
| +194.79% | ||
| +5,387.64% | ||
| +36.74% | ||
| +77.14% | ||
| +84.07% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $3.77 | ||
| $3.07 | ||
| SMA 200 vs Price | -18.45% | |
| $4.32 | ||
| SMA 50 vs Price | +14.72% | |
| 0.77 | ||
| $0.26 | ||
| 36.96 | ||
| 68.79% | ||
| 92.16% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $41.43M | ||
| -$0.41 | ||
| $21.59M | ||
| 52.12% | ||
| -$68.00M | ||
| -212.00% | ||
| -$36.70M | ||
| -88.57% | ||
| -$48.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.84 | ||
| 1.73 | ||
| 1.73 | ||
| - | ||
| 4 | ||
| -0.39 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 5.12 | ||
| 3.83 | ||
| -22.47 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $131.03M | ||
| $260.31M | ||
| $392.55M | ||
| $287.07M | ||
| $261.52M | ||
| $166.27M | ||
| $109.65M | ||
| $24.52M | ||
| $18.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $78.13M | ||
| $89.59M | ||
| $19.84M | ||
| $0.00 | ||
| $19.81M | ||
| $0.00 | ||
| -$6.44M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $22.10M | ||
| -$102.63M | ||
| $89.80M | ||
| $3.84M | ||
| $18.27M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Clear Street | ||
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Oppenheimer | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| Oppenheimer | → | |
| JMP Securities | → | |
| Citigroup |
Analyst sentiment
Institutional ownership
Screeners with CLLS
FAQ
What is the ticker symbol for Cellectis S.A.?
The ticker symbol for Cellectis S.A. is NASDAQ:CLLS
Does Cellectis S.A. pay dividends?
No, Cellectis S.A. does not pay dividends
What sector is Cellectis S.A. in?
Cellectis S.A. is in the Healthcare sector
What industry is Cellectis S.A. in?
Cellectis S.A. is in the Biotechnology industry
What country is Cellectis S.A. based in?
Cellectis S.A. is headquartered in France
When did Cellectis S.A. go public?
Cellectis S.A. initial public offering (IPO) was on March 24, 2015
Is Cellectis S.A. in the S&P 500?
No, Cellectis S.A. is not included in the S&P 500 index
Is Cellectis S.A. in the NASDAQ 100?
No, Cellectis S.A. is not included in the NASDAQ 100 index
Is Cellectis S.A. in the Dow Jones?
No, Cellectis S.A. is not included in the Dow Jones index
When was Cellectis S.A. last earnings report?
Cellectis S.A.'s most recent earnings report was on November 7, 2025
When does Cellectis S.A. report earnings?
The next expected earnings date for Cellectis S.A. is March 12, 2026
Data Sources & References
- CLLS Official Website www.cellectis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1627281/000119312525272443/0001193125-25-272443-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1627281/000095017025039038/0000950170-25-039038-index.htm
- CLLS Profile on Yahoo Finance finance.yahoo.com/quote/CLLS
- CLLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clls